![](https://cdn.images.express.co.uk/img/dynamic/22/590x/938783_1.jpg)
SHARES in FTSE 100 drugmaker Shire soared 430p to 3500p after it emerged as a £35billion takeover target for Japan’s biggest pharma company. Takeda Pharmaceutical is considering an approach to Shire as it looks to strengthen its core therapeutic areas of oncology and neuroscience.
0 Comments